The University of Texas at Dallas | School of Behavioral and Brain Sciences
Chronic pain is a significant problem of world-wide importance. The most common cause of long-term disability in the world, the annual cost of chronic pain in the U.S. is as high as $635 billion a year; more than cancer, heart disease and diabetes care combined. Additionally, migraine is the second leading cause of chronic pain. CAPS is aggressively pursuing lines of research aimed at alleviating suffering from pain and improving the lives of people with chronic pain and migraine.
About Us
Our mission is to elucidate the fundamental mechanisms underlying chronic pain and migraine
Director’s Welcome
The foundation of our endeavors is funding from NIH and other federal sources. CAPS faculty are currently supported by over $10,000,000 in funding.
PHD Programs
Due to our multidisciplinary approach, our faculty accepts students through three different programs.
Sensoryomics Dashboard
Compare gene expressions across human and mouse models
Our Research
CAPS Faculty have an interest in several research areas including chronic pain, migraine, neuroimunology and RNA.
Our Entrepreneurship
CAPS faculty members have started four companies to bridge the gap between basic research and drug delivery.
Learn More
Giving
Many forms of chronic pain have been treated with prescription opiates, yet recent research suggests that opiates may increase pain when administered for certain types of chronic pain. Moreover, opioids can be dangerous, addictive drugs. With over one third of the US population suffering from chronic pain, it is critical that we find solutions to better treat pain. With your help researchers at the Center for Advanced Pain Studies are actively making headway in discovering non-opioid pain medicines.